# reload+after+2024-01-22 01:35:21.354597
address1§25 Norman Way
address2§Over
city§Cambridge
zip§CB24 5QE
country§United Kingdom
phone§44 1223 967 943
website§https://www.4basebio.com
industry§Biotechnology
industryKey§biotechnology
industryDisp§Biotechnology
sector§Healthcare
sectorKey§healthcare
sectorDisp§Healthcare
longBusinessSummary§4basebio PLC engages in the research, development, manufacturing, and commercialization of synthetic DNA and RNA products, and targeted non-viral vector solutions in the United States, Europe, and internationally. It provides AVV and Lentivirus manufacturing services for use in gene therapies and vaccines. The company offers access to its targeted non-viral delivery platform, Hermes. It serves biotech, pharma, and contract development and manufacturing organization. The company was formerly known as 4basebio UK Societas and changed its name to 4basebio PLC in July 2021. 4basebio PLC was founded in 2008 and is based in Cambridge, the United Kingdom.
fullTimeEmployees§78
companyOfficers§[{'maxAge': 1, 'name': 'Dr. Heikki  Lanckriet Ph.D.', 'age': 46, 'title': 'CEO, Chief Scientific Officer & Executive Director', 'yearBorn': 1977, 'fiscalYear': 2022, 'totalPay': 448900, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. David  Roth', 'age': 56, 'title': 'CFO, Company Secretary & Executive Director', 'yearBorn': 1967, 'fiscalYear': 2022, 'totalPay': 323100, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Mark  Cooper', 'title': 'Head of Manufacturing', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}]
compensationAsOfEpochDate§1672444800
maxAge§86400
priceHint§2
payoutRatio§0.0
beta§1.069
priceToSalesTrailing12Months§243.60593
currency§GBp
forwardEps§-60.0
exchange§LSE
quoteType§EQUITY
shortName§4BASEBIO PLC ORD EUR1.00
longName§4basebio PLC
firstTradeDateEpochUtc§1613548800
timeZoneFullName§Europe/London
timeZoneShortName§GMT
uuid§8127191e-c65f-3ba9-88e5-ef8f45de7097
messageBoardId§finmb_700375712
recommendationMean§2.0
recommendationKey§buy
quickRatio§2.438
grossMargins§0.80508006
ebitdaMargins§0.0
trailingPegRatio§None
